Early High-Titer #Plasma Therapy to Prevent Severe #Covid-19 in Older Adults

Therapies to interrupt the progression of early coronavirus disease 2019 (Covid-19) remain elusive. Among them, convalescent plasma administered to hospitalized patients has been unsuccessful, perhaps because antibodies should be administered earlier in the course of illness. We conducted a randomized, double-blind, placebo-controlled trial of convalescent plasma with high IgG titers against severe acute respiratory syndrome … Continue reading Early High-Titer #Plasma Therapy to Prevent Severe #Covid-19 in Older Adults